Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

Jesper Brok; Lise L Gluud; Christian Gluud

doi:10.1111/j.1572-0241.2006.00505.x

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

Jesper Brok, Lise L Gluud, Christian Gluud

Copenhagen Trial Unit Rigshospitalet

38 Citationer (Scopus)

Abstract

Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.

Originalsprog	Engelsk
Tidsskrift	American Journal of Gastroenterology
Vol/bind	101
Udgave nummer	4
Sider (fra-til)	842-7
Antal sider	6
ISSN	0002-9270
DOI	https://doi.org/10.1111/j.1572-0241.2006.00505.x
Status	Udgivet - apr. 2006

Adgang til dokumentet

10.1111/j.1572-0241.2006.00505.x

Citationsformater

@article{1a592b69824c4596a6eee70a22e98974,

title = "Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials",

abstract = "Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.",

keywords = "Antiviral Agents, Hepatitis C, Chronic, Humans, Randomized Controlled Trials as Topic, Ribavirin",

author = "Jesper Brok and Gluud, {Lise L} and Christian Gluud",

year = "2006",

month = apr,

doi = "10.1111/j.1572-0241.2006.00505.x",

language = "English",

volume = "101",

pages = "842--7",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

number = "4",

}

TY - JOUR

T1 - Ribavirin monotherapy for chronic hepatitis C infection

T2 - a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

AU - Brok, Jesper

AU - Gluud, Lise L

AU - Gluud, Christian

PY - 2006/4

Y1 - 2006/4

N2 - Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.

AB - Adding ribavirin to interferon improves treatment response for patients with chronic hepatitis C, but the effects of ribavirin monotherapy are unclear. We conducted a systematic review to assess the benefits and harms of ribavirin monotherapy for patients with chronic hepatitis C.

KW - Antiviral Agents

KW - Hepatitis C, Chronic

KW - Humans

KW - Randomized Controlled Trials as Topic

KW - Ribavirin

U2 - 10.1111/j.1572-0241.2006.00505.x

DO - 10.1111/j.1572-0241.2006.00505.x

M3 - Journal article

C2 - 16494584

SN - 0002-9270

VL - 101

SP - 842

EP - 847

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 4

ER -

Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater